Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) EBT Margin: 2013-2025

Historic EBT Margin for Ocular Therapeutix (OCUL) over the last 13 years, with Sep 2025 value amounting to -467.35%.

  • Ocular Therapeutix's EBT Margin fell 18489.00% to -467.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -443.25%, marking a year-over-year decrease of 21733.00%. This contributed to the annual value of -259.05% for FY2024, which is 10551.00% down from last year.
  • Latest data reveals that Ocular Therapeutix reported EBT Margin of -467.35% as of Q3 2025, which was up 6.40% from -499.31% recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's EBT Margin ranged from a high of -142.09% in Q3 2023 and a low of -589.60% during Q1 2025.
  • In the last 3 years, Ocular Therapeutix's EBT Margin had a median value of -247.86% in 2024 and averaged -291.40%.
  • As far as peak fluctuations go, Ocular Therapeutix's EBT Margin spiked by 106,001bps in 2021, and later crashed by 37,472bps in 2025.
  • Over the past 5 years, Ocular Therapeutix's EBT Margin (Quarterly) stood at -160.25% in 2021, then surged by 1,257bps to -147.67% in 2022, then slumped by 598bps to -153.65% in 2023, then tumbled by 13,326bps to -286.92% in 2024, then tumbled by 18,489bps to -467.35% in 2025.
  • Its last three reported values are -467.35% in Q3 2025, -499.31% for Q2 2025, and -589.60% during Q1 2025.